Detalles de la búsqueda
1.
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
Clin Exp Rheumatol
; 40(7): 1258-1266, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34251312
2.
Thromboelastometry demonstrates endogenous coagulation activation in nonsevere and severe COVID-19 patients and has applicability as a decision algorithm for intervention.
PLoS One
; 17(1): e0262600, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35030224
3.
COVID-19 was not associated or trigger disease activity in spondylarthritis patients: ReumaCoV-Brasil cross-sectional data.
Adv Rheumatol
; 62(1): 45, 2022 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-36419163
4.
High Levels of Polypharmacy in Rheumatoid Arthritis-A Challenge Not Covered by Current Management Recommendations: Data From a Large Real-Life Study.
J Pharm Pract
; 34(3): 365-371, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31451091
Resultados
1 -
4
de 4
1
Próxima >
>>